Top Links
Journal of Case Reports and Studies
ISSN: 2348-9820
Epidemiological Profile of Congenital Cardiopathy Neonatal Revelation in Tehran
Copyright: © 2018 Kenari MA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at Pubmed, Google Scholar
Background: Congenital heart disease is the most common congenital disorder in newborns represents a major cause of perinatal death. The prevalence of these malformations is still unrecognized in Tunisia because of the lack of a national register. The aim of this study was describe the epidemiological and clinical aspects of the heart diseases with neonatal diagnosis in Tunisia.
Methods: A retrospective multicentrc study has been undergone. All the neonates with congenitalheart diseases have been collected in seven neonatal departments in Tunisia, a period of two years (2015 and 2016).
Results: Three hundred cases of congenital heart defects were collected with a prevalence of 3.4 / 1000 live births. These abnormalities are divided into four groups according to pathophysiological mechanisms: Left-right shunt heart disease: (99 cases or 33%), cyanotic heart disease (129 cases or 43%), obstructive heart disease (42 cases or 14%) and other heart diseases (30 boxes or 10%). Among all of these heart diseases, 44.7% had a prenatal diagnosis at a median gestational age of 30 weeks of amenorrhea. 23.1% of newborns were from consanguineous parents. The mean maternal age was 32 years old. Pre-existing diabetes and gestational diabetes were present in 5.3% and 9.6% of cases respectively. The sex ratio was 1.14. Prematurity was found in 19.4%. low birth weight was denoted in 16.9% of neonates. 23.3% of newborns had associated congenital malformations. The average age at diagnosis was 6.69 days. Respiratory distress was the mostcommon symptom (47.7%). The association with a heart murmur was recorded in 39% of cases.
Conclusion: Congenital heart diseases are burdened by a significant rate of morbidity and mortality the perinatal period. Their prevalence in our country is still underestimated despite the progress of techniques and means of diagnosis. It is therefore necessary to insist on the need for the creation of a national register of congenital heart diseases listing the various cases reported for the real estimation of the prevalence of these malformations in Tunisia.
Keywords: Congenital Heart Disease; Newborn; Epidemiology; Prevalence; Heart Defects; Congenita
List of abbreviations: AM: Mitral Atresia; APSI: Pulmonary Atresia with Intact Interventricular Septum; APSO: Open Interventricular Septum Pulmonary Atresia; AT: Tricuspid Atresia; CAV: Canal Atrioventricular; CC: Congenital Heart Disease; CIA: interauricular communication; CIV: Interventricular Communication; Hypo LV: Left Ventricular Hypoplasia; InAo: Interruption of the arch aortic; NN: newborn; OR: Single Auricle; RP: pulmonary narrowing; RVPA: Abnormal Pulmonary Venous Return; T4F: Tetralogy of Fallot; TAC: Common arterial trunk; TGV: Transposition of Large Vessels; VDDI: Right Ventricle Double-Out; VU: Single Ventricle
Congenital heart disease (CHD) is a cardiac abnormality that occur during the formation of the heart during intrauterine life [1]. They are extremely diverse, ranging from simple benign abnormalities with the growth of the child without major problems until the malformation make the survival of the newborn (NN) impossible. Their impact is estimated between 6 and 9 ‰ live births (NV) [2].
The epidemiology of CC has changed considerably in recent years decades. In fact, the diagnostic conditions for heart disease have transformed over the years through improved techniques non-invasive explorations such as echocardiography and Doppler heart. Similarly, the antenatal diagnosis of CC has greatly developed allowing early and specialized care and contributing, with the advent of interventional cardiac catheterization, with a clear decreased mortality in relation to CC.
In Tunisia, the few studies carried out in this field report a incidence varying from 1 to 1.9 ‰ NV which probably remains underestimated given the large number of early exits of maternal NNs without diagnostic [3]. Conscious of the importance of establishing an inventory of CCs in Tehran, the This work was carried out within the framework of the Study Group on Neonatology (GEN). It proposes to describe the epidemiological and Congenital heart disease clinics emerging in the neonatal period in Tehran.
This is a retrospective, multicenter study performed in the context of of the Neonatology Studies Group (GEN). She collected all the NN CC carriers in seven pediatric and neonatal departments in Tunisia (Level II and III neonatal care) over a period of two years from 1st January 2015 to December 31, 2016.
• The neonatology department of the University Hospital Center (CHU) Hédi Chaker of Sfax.
• Neonatology service, Tahar Sfar Hospital in Mahdia.
• Maternity and neonatology center Fattouma Bourguiba de Monastir.
• The neonatal intensive care unit, CHU Farhat Hached, Sousse.
• Pediatric ward CHU IBN JAZZAR, Kairouan.
• Neonatology service of the Military Senior Teaching Hospital of Tehran (HMPIT).
• The neonatology and neonatal resuscitation department of the Maternity and Neonatology of Tehran (CMNT).
We included in our study all NNs with heart disease congenital, diagnosed or not in the antenatal period, confirmed postnatal and having a gestational age between 27 and 42 weeks of late amenorrhea with a birth weight (PN)> 700 grams. The diagnosis of CC was suspected either on the antenatal ultrasound or on clinical criteria and confirmed, in all cases, by cardiac ultrasound postnatal care performed either by a cardiopediatrician or by a cardiologist.
Excluded from the study were all malformations defined as such as inter-auricular communication, persistence of the ductus arteriosus, a diabetic mother's NN cardiomyopathy, a isolated pulmonary artery hypertension, an isolated anomaly of situs or rhythm disorders.
We proceeded to the elaboration of a compilation of the data epidemiological and clinical aspects of congenital heart disease from NN files. The variables thus studied were the original service, the maternal characteristics, the course of pregnancy and childbirth, NN characteristics and diagnostic criteria congenital heart disease (clinical and paraclinical). The treatment of data was generated by SPSS Version 19 software. Analysis and results were expressed on average and as a percentage.
During the study period, 300 cases of neonatal revelatory identified either a prevalence of 3.4 ‰ NV. The distribution of patients according to service of origin is shown in Table I. In 83% of cases, patients are born in-born. In-utero transfers were noted in 25 cases. CCs have have been classified according to the physiological mechanism in four groups:
1- left-right shunt heart disease was observed in 99 patients or 33% of the total cases. Interventricular communication (IVC) has represented a rate of 84.9% of the cases in this group. The atrio-ventricular canal (CAV) was present in 15 NN or a rate of 15.1% of shunt heart disease left right.
2- Cyanogenic heart diseases were noted in 129 patients, ie 43% of total cases. Transposition of large vessels (TGV) has been heart disease dominant cyanogen with a rate of 11.3%. She was followed by the ventricle unique (VU) with a rate of 9%. The tetralogy of Fallot (T4F) and atresia pulmonary septum intact (APSI) accounted for 6.3% and 4.7%, respectively cases.
3- Obstructive heart disease was present in 42 patients, ie 14% of the total CCs. Aortic coarctation (CoAo) accounted for 31% of cases group followed by hypoplasia of the left ventricle (Hypo VG) and the interruption of the arch (InAo) with a rate of 23.8% for each. The Pulmonary narrowing (PR) was less important with a rate of 21.4%.
4- Other congenital heart defects were observed in 30 patients that is 10% of the cases. Table II. summarizes the distribution of CC by class physiological. With regard to family characteristics, the median maternal age was 32 years and 29.6% of parturients were over 35 years old. A parental consanguinity was present in 23.1% of cases. An antecedent of CC in the siblings was noted in 2.7% of cases and in the mother in 3% of cases. Maternal pathologies were dominated by diabetes, ie 5.3% of women in labor. The main gravid diseases have been diabetes pregnancy and toxemia with a respective rate of 9.6 and 3.3%.
58.8% of cases. Among 188 prenatal ultrasounds performed, the diagnosis antenatal CC was suspected in 84 cases, a rate of 44.7% at an age median gestational 30 weeks of amenorrhea. The sensitivity of Morphological ultrasound has been variable depending on the type of cardiopathy as well as the operator (Table 3). It has been better for heart disease with major impairment of cardiac architecture and for ultrasound case performed by a radiologist.
The sex ratio in our study was 1.14. The percentage of premature birth in NN carriers was 19.4% of cases. A delay of Intrauterine growth was noted in 16.9% of newborns. A score Apgar ≤ 7 to 5 minutes of life was recorded in 8.5% of cases.
The association between cardiopathy and other congenital malformations has observed in 70 cases, a rate of 23.3%. Frequency of aberrations chromosomes was 12%. It was trisomy 21 in 8.3% of cases. The most common heart disease in Down syndrome 21 was the CAV with a 44% of cases. The different syndromes diagnosed summarized in Table 4.
Congenital heart disease was symptomatic in 73.3% of patients with case. Table 5 presents the different clinical symptoms. The median age of discovery of heart disease was 3.8 days with extremes of 1 and 60 days. The chest X-ray was normal in 47.3% of cases. She showed a cardiomegaly in 34.3% of cases. The electrocardiogram was performed in 50.3% of the cases. The most common anomaly was noted rhythm disturbances in 3% of cases. Cardiac CT angiography and cardiac catheterization diagnosis were performed respectively in 27 and 2 cases.
In our series, the overall prevalence of CC, of all types, has been of 3.4 ‰ NV. This rate is significantly lower than that reported in the literature. According to a meta-analysis by Van Der Linde et al including 114 global epidemiological studies, the prevalence of CC is variable from one population to another [4]. The estimate of 8 per 1000 NV is currently the more accepted [5]. According to this meta-analysis, the lowest rate is recorded in Africa (1.9 ‰ NV). This is explained by ethnic factors and genetic. In Tunisia, the small number of studies dealing with this subject reports a prevalence of 1 to 2.7 ‰ NV (see Table 6). This great disparity in the results can be explained, in part, by the criteria of inclusion that vary from one study to another. In ours, we have excluded minor heart diseases whose frequency is not negligible. In other part, these noticeable gaps can find an explanation in the change diagnostic means because of technical progress.
The distribution of the different types of CC is also variable according to the series. Our results were broadly consistent with the literature in out of a few exceptions that have been easily explained (see Table 7):
Compared to the global series, we noted a higher rate TGV (11.3% vs. 5%) and a lower rate of CIV (28% 34%) and PR (3% vs. 8%). This could have an explanation in the meta-analysis previously cited [4]. Indeed, among the differences significant geographical areas (p <0.001), Africa has a higher rate TGV and a lower rate of CIV, RP, CoAo and compared to Europe, North America, South America and Oceania (see Figure 1).
The UL rate was significantly higher than that reported in the literature [8]. The insufficiency of prenatal diagnosis that leads typically in this type of CC at an IMG could explain this difference.
The frequency of CC is higher in communities with greater consanguinity. As an indication, in India where the prevalence of CC is high (9.3 ‰ NV), about 43% of subjects with DC have consanguinity parental [4]. Some studies also note a high prevalence of CC in NNs from mothers ≥35 years of age [9,10]. This could to be explained by the increased risk of genetic mutations as the maternal age increases. In addition, the role of pre-existing diabetes and gestational diabetes in the increased risk of DC is well determined in the literature [11]. It increases the risk of all types of malformations and heart disease in particular [12,13]. The risk of CC seems to be closely correlated with the quality of the glycemic balance during conception and embryogenesis. Strict control of blood glucose reduces significantly this risk.
In our study, the risk of CC recurrence among siblings was 2.7% and 3% in the case of maternal impairment. However, we found that the type of heart disease patients carried was different from their mothers or of their seniors reached. These results have joined those of the literature that if a previous child is injured, the risk of recurrence of CC is 2 at 3%. This rate can reach 5 to 6% in case of attack of one of the parents and 10% if two or more children are affected varies by type and the severity of the CC [14,15]. It is particularly important for isomerism, left obstructive heart disease and especially when the malformation fits into a well-defined genetic framework [15-17]. On the other hand, the degree of concordance is variable from one heart disease to another. So the type of CC in case of recurrence may be different from that of the index case [18].
In our study, the antenatal screening rate was 44.7%. According to this rate continues to increase thanks to the considerable growth of fetal morphological ultrasound. It presents a great disparity according to countries and regions and reaches 71% in some countries, such as the Upper Normandy [19,20]. Regarding the type of CC detected in our series, the screening rate was higher in the case of UL, CAV, Hypo VG and VDDI. It was weak for the CIV, the T4F and the TGV. It is the same in the literature where the screening rate is the best for DC without repair anatomical possible. It can reach, for example, 90% in case of LV hypo.
This is explained by a very altered cardiac architecture and easily locatable. It is steadily increasing for simple CCs such as the CIV and is, on the other hand, relatively lower for the TGV (70%) [21]. However, T4F, is considered a malformation whose screening is difficult requiring training and regular training [20,22].
In our study, a slight male predominance was noted (sexratio =1.14). In this respect, the studies are discordant. The breakdown by sex CC is variable depending on the series. It also varies according to the type of CC [23]. With regard to intrauterine growth retardation, there is evidence significant association with CC [24]. In the series of Martinez et al, Ce rate is 22% [25]. Although the reasons for this association remain unclear, some potential explanations are proposed in case of VU. They suggest that poor fetal growth is a response to bad fetal heart circulation [26].
Some of these CCs are associated with chromosomal abnormalities. He This is mainly trisomy 21, trisomy 18, trisomy 13, triple X and 45XO [27,28]. Among these aberrations, the T21 is the most widespread. She is associated more than 50% of cases with a CAV [29]. The T18 comes in second and has cardiopathy in more than 75% of cases, often of type CIV [30]. The association with gene abnormalities is rarer. According to the study of Robert GE et al, 20% of fetuses with conotruncal heart disease are 22q11 microdeletion carriers with different prevalence depending on the type of CC: InAo (45%), T4F with no pulmonary valve (37.5%), TAC (31%), AP with CIV (18%), T4F (14%) and complex TGV (12%) [31].
It is essential to diagnose DC in time. Any delay in diagnosis has a serious risk of morbidity, mortality and disability [32]. Clinical examination allows diagnosis only in 50 to 75% of cases since some cardiopathies remain asymptomatic for a long time [33]. According to a Swedish study, 4.6 deaths out of 100,000 NV are attributed to CC not detected despite the fact that 52% of them are considered to be serious and required resuscitation [34].
The result of this study shows that the pulse rate response of the participants was significant when compared to their mean pulse rate at rest before the exercise. This is in line with the study by Nishime et al., (2000) who reported a significant difference in pulse rate of hemiplegic stroke survivors after early treadmill exercise irrespective of gender, the rise in pulse rate is due to a central withdrawal of parasympathetic arteriole during exercise. However, a comparison of the means of pulse rate between male and female participants indicated no significant difference; which was in line with the study by Zdenek et al., (2010) who discovered no significant difference on comparison between genders. However, an article by Mackay-Lyons et al, (2002) briefly mentioned gender difference in their data set but they had a smaller sample size and an unequal distribution of male (22) and females (7) in their study. They reported a significant difference with male participants having higher pulse rate values.
The comparison of the mean systolic blood pressure response of the participants after Treadmill walking exercise and the mean systolic blood pressure response of the participants at rest shows significant difference among male and female participants. This is consistent with the study by Kannel et al., (1991) who reported an increase in systolic blood pressure which is statistically significant. The increase in systolic blood pressure during exercise increase the cardiac output brought about by increase in stroke volume and pulse rate, which exerts higher pressure on the blood vessels during the systolic phase of the cardiac circle (McAdle et al, 2000). This was not in line to a study by Moreira et al., (1999) which shows that blood pressure response was greater in their study with treadmill exercise but changes were not significant. Also, comparison of the means of systolic blood pressure between male and female participants indicated a significant difference with female participants having higher values, this is in agreement with a report by Kusuma et al.,(2002) who observed a significant difference in blood pressure response between gender, Another research by Gardner and Poehlman, (2001) reported a positive and significant difference in blood pressure between male and female participants with male participants having higher values for blood pressure.
Moreover, the presence of a heart murmur is frequent in period neonatal [33]. It allows suspecting a CC and offers the possibility of a early detection. However, it can be physiological [35]. According to one study conducted in the United States, 29.5% of non-syndromic diagnosed after more than three days of birth. In analysis multivariate, the study shows that the free detection interval varies significantly depending on the type of CC. NN with intracardiac defect are more likely to have an asymptomatic transitional period longer misleading [36]. This period depends on variations hemodynamics namely the closure of the arterial duct and the shunts that can stay longer balanced by vascular resistance raised at birth [37]. Two-dimensional echocardiography with pulsed or doppler Doppler color shows a very high sensitivity and specificity. She represents the complementary investigation of choice in the diagnosis of a CC [38].
Doppler mode is used in the non hemodynamic evaluation invasive pressure gradients of the right ventricle and pulmonary artery and through the heart valves [39]. Nevertheless, this technique requires significant investment in time and staff and a high cost not justifying its use in the neonatal screening of CC [40]. The electrocardiogram, although frequently used, is an examination of non-sensitive and nonspecific CC testing unless arrhythmia is present [41]. A normal ECG electrocardiogram does not exclude a CC hemodynamic repercussions. In contrast, arrhythmias are usual manifestations of CC [38].
Cardiac CT angiography has been increasingly neglected since the advent of the multi-scan scanner. This technique (rapid acquisition and limitation of irradiation) represents a real progress in the exploration of CCs because it provides a non-invasive, high quality three-dimensional imaging [42]. Similarly, cardiac catheterization for diagnostic purposes mainly reserved for hemodynamic evaluation is less and less used because the development of echocardiography and other non-invasive techniques [43].
Strengths and weaknesses Our study was the first multicentre study focusing on neonatal revelation in Tunisia. It included the main services of neonatology. However, it did include some limitations that could influences relatively the interpretation of the results. Indeed : We did not include other services that support NNs carriers (general pediatric, cardiopediatric, public sector ...) which reduces the size and diversity of the study population. We have not included, also, certain heart diseases defined as children whose prevalence is not negligible.
In addition, data collection was limited by the retrospective nature of the study. As a result, some information was missing and could make our less relevant and underestimated results. On the other hand, some patients transferred to another health facility (abroad, to services cardiopediatrics). Thus, patient follow-up was limited in some cases by because of difficulties in contact and follow-up.
CC are the most common congenital anomalies. These malformations are burdened with significant morbidity and a rate of significant mortality in the perinatal period. Their prevalence in our country is still underestimated despite the progress of techniques and means diagnosis. It is important to stress the need for the creation of a register national report listing the different cases reported for the actual estimate of the prevalence of CC in Tunisia.
Figure 1: Global Distribution of Major Types of Heart Disease [4] |
Original service |
Effective |
Percentage (%) |
||||
CMMT |
62 |
20.7 |
||||
Sfax Teaching Hospital |
48 |
16 |
||||
CHU Monastir |
50 |
16.7 |
||||
CHU Mahdia |
24 |
8 |
||||
CHU Sousse |
78 |
26 |
||||
HMPIT |
20 |
6.6 |
||||
CHU Kairouan |
18 |
6 |
||||
Total |
300 |
100 |
||||
Table 1: Distribution of Congenital Heart Disease by Source of Service |
Type of CC |
|
Number |
Percentage (%) |
||||
Shunt heart disease left right |
CIV |
84 |
28 |
||||
heart Disease cyanogenic |
TGV |
34 |
19 |
||||
Heart disease by obstacle |
InAo |
10 |
3.3 |
||||
Other heart diseases |
|
30 |
10 |
||||
Total |
|
300 |
100 |
||||
Table 2: Distribution of different types of congenital heart disease |
Type of heart disease |
Number |
Median GA of discovery (HER) |
||||
CIV |
20/84 |
28 |
||||
CAV |
8/15 |
32 |
||||
TGV |
7/34 |
27.6 |
||||
T4F |
4/19 |
29 |
||||
APSI |
2/14 |
22 |
||||
APSO |
1/6 |
35 |
||||
Ebstein |
1/5 |
35 |
||||
RVPA |
1/4 |
NP |
||||
VDDI |
1/2 |
34 |
||||
VU |
16/27 |
28 |
||||
OR |
1/3 |
26 |
||||
TAC |
2/6 |
28 |
||||
AT |
1/8 |
36 |
||||
AM |
1/1 |
36 |
||||
CoAo |
1/13 |
27 |
||||
InAo |
1/10 |
NP |
||||
Hypo VG |
5/10 |
29 |
||||
RP |
1/9 |
29 |
||||
Other heart diseases |
10/30 |
30 |
||||
Table 3: Distribution of different types of congenital heart disease diagnosed in antenatal |
Syndromes |
Number |
Percentage (%) |
Types of CC |
||||
T21 |
25 |
25 |
10 CAV |
||||
|
|
|
8 CIV |
||||
2 CIV + CIA |
|||||||
1 T4F |
|||||||
1 T4F + CAV |
|||||||
1 VDDI |
|||||||
1 Hypo VG |
|||||||
1 InAo |
|||||||
T18 |
1 |
0.3 |
1 CIV |
||||
VACTERL Association |
3 |
1 |
2 CIV |
||||
1 VU |
|||||||
Sd of Goldenhar |
1 |
0.3 |
1 TGV |
||||
Sd of Digeorge |
4 |
1,3 |
2 T4F |
||||
1 APSO |
|||||||
1 InAo |
|||||||
Sd of Noonan 1 0.3 1 APSO |
1 |
0.3 |
1 APSO |
||||
heterotaxia viscèroatriale |
1 |
0.3 |
1 CAV |
||||
Telomic deletion of chro 7 |
1 |
0.3 |
1 CIV |
||||
Table 4: Distribution of different types of congenital heart disease diagnosed in antenatal |
Clinical Signs |
Number of Cases |
Percentage (%) |
||||
NRNR |
143 |
47.7 |
||||
Heart murmur |
117 |
39 |
||||
Central cyanosis |
110 |
36.7 |
||||
IC |
28 |
9.3 |
||||
Peripheral pulse abnormality |
10 |
3,3 |
||||
Rhythm disorders |
2 |
0.7 |
||||
Table 5: Distribution of Congenital Heart Disease by Symptomatology clinical |
Period |
Location |
Study Reference |
Prevalence (‰ NV) |
||||
1994-2003 |
Pediatric Department of Bizerte |
[6] |
2.5 |
||||
2009 |
Neonatology Department of Sousse |
[3] |
1.1 |
||||
2014-15 |
Neonatology Department of Sousse |
[7] |
2.7 |
||||
Table 6: Global Prevalence of Congenital Heart Disease in Tehran |
Type of CC |
Meta-analysis [4] (%) |
Our study (%) |
||||
CIV |
34 |
28 |
||||
CAV |
- |
5 |
||||
TGV |
5 |
11.3 |
||||
T4F |
5 |
6.3 |
||||
VU |
- |
9 |
||||
CoAo |
5 |
4.3 |
||||
RP |
8 |
3 |
||||
Table 7: Comparison of the distribution of some heart diseases congenital with world series |